Effectiveness of homoeopathic medicine in the management of onychomycosis

INTERVENTION: Intervention1: Individualized Homoeopathic Medicine: After enrollment patients are randomly allocated into Group A individualized homoeopathic medication or Group B placebo For Group A patients Appropriate potentized individualized homoeopathic medicine will be administered in minimum dose in appropriate potency according to the need of case Medicine will be administered orally Repetition of the medicine and change of potency or remedy if required will be based on clinical assessment and homoeopathic principles during follow up Participants in the intervention arm will receive individualized homoeopathic medicine for a period of 6 months Control Intervention1: PLACEBO: Participants randomized to the control group will receive placebo identical in appearance and packaging Placebo will be administered orally for a period of 6 months The placebo will consist of saccharum lactis and will be administered according to the same dosing schedule as the intervention group Both participants and investigator responsible for outcome assessment will remain blinded Rescue medication will be permitted in both groups as per need of patient CONDITION: Health Condition 1: B351‐ Tinea unguium PRIMARY OUTCOME: Changes in the OSI Score to asses disease severity in onychomycosisTimepoint: at baseline 2nd month 4th month 6th month SECONDARY OUTCOME: 1 Changes in the Nail QoL score from baseline at 2nd 4th and 6th months ; 2 Proportion of patients to achieve clinically meaningful improvement , ; defined as greater than or equal to 50 percentage reduction in the Onychomycosis Severity Inde XOSIscore ; over a follow‐up period of 6 months. ; ; Timepoint: at baseline 2nd month 4th month 6th month INCLUSION CRITERIA: 1.Age:18 to 75 years of all genders 2.Involvement of one or more fingernails or toenails. 3.Positive KOH microscopy for fungal elements 4.Patient is willing for the required investigation